Jump to navigation
Enter the article’s url One of our curators will take care of it as soon as possible!
Subscribe to our weekly newsletter.
There are many obstacles to bringing the power of 21st-century technology to the NHS. But that shouldn't stop us trying.
One in three scholars in field ‘deeply concerned’ about future research career prospects
New technologies could deliver the benefits of nature without the hassle of life
Consider biomedical preclinical and clinical research, in which the trusted service involves the exchange of papers, data, software, reagents, and so on.
Gene-edited seedless tomatoes don’t need pollinating to produce fruit – which could come in useful at a time when bees are on the decline
The synthetic biology community is divided.
Entrepreneurs are betting on apps that improve—or just replace—prescription medication.
Contaminated samples, faulty studies and inadequate training have created a crisis in laboratories and industry, slowing the quest for new treatments and cures.
While the US accounts for 75% of global digital health deal share, deal flow to international startups continues to climb.
US Food and Drug Administration says firm can provide consumers with information on genetic risks.
Several pricey drugs projected as best-sellers have flopped, unnerving the industry. Is the era of the biotech blockbuster over?
The World Health Organization says cases are climbing where immunisation coverage has dropped.
What happens when diagnosis is automated?
Decision contrasts with U.S. ruling in long-standing battle over genome-editing tool
A data set interrogation tool in the field of cell and molecular biology.
New techniques being used to produce our food or shape the environment raise regulatory questions.
Wolfram Schultz, Peter Dayan, and Ray Dolan have today been awarded the €1 million Brain Prize by Denmark’s Lundbeck Foundation.
WHO today published its first ever list of antibiotic-resistant "priority pathogens"—a catalogue of 12 families of bacteria that pose the greatest threat to human health.
Researchers at Stanford University have created an AI algorithm that can identify skin cancer as well as a professional doctor.
Doudna and Berkeley may appeal the ruling in favor of MIT and Harvard. There is big money at stake.